Study summary

To assess the safety of intravitreal Zimura™ (complement factor C5 inhibitor) administered in combination with Lucentis® 0.5 mg in treatment naïve subjects with neovascular age related macular degeneration (NVAMD)

Additional Study Details

Phase
Phase 2
Product
avacincaptad pegol
Product
Avacincaptad Pegol
Lucentis
Type
Interventional
Masking
None (Open Label)
Enrollment number
64
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English
Protocol
Available Language(s): English
Statistical Analysis Plan (SAP)
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for ZIMURA in combination with LUCENTIS in patients with Neovascular Age Related Macular Degeneration (NVAMD)? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Vitreo Retinal Consultants & Surgeons
    Wichita, Kansas, United States, 67214
    Completed
    Sierra Eye Associates
    Reno, Nevada, United States, 89502
    Completed
    Retina Consultants of Southern California
    Redlands, California, United States, 92374
    Completed
    Retinal Consultants Medical Group
    Sacramento, California, United States, 95841
    Completed
    Ophthalmic Consultants of Boston
    Boston, Massachusetts, United States, 02114
    Completed
    Strategic Clinical Research Group
    Willow Park, Texas, United States, 76087
    Completed
    Retina Consultants of Nevada
    Henderson, Nevada, United States, 89052
    Completed
    Charleston Neuroscience Institute
    Ladson, South Carolina, United States, 29456
    Completed
    Orange County Retina Medical Group
    Santa Ana, California, United States, 92705
    Completed
    Retina Vitreous Surgeons of CNY, PC
    Syracuse, New York, United States, 13224
    Completed
    Retinal Research Institute
    Phoenix, Arizona, United States, 85053
    Completed
    Retina Associates SW, PC
    Tucson, Arizona, United States, 85710
    Completed
    Retina Consultants of Orange County
    Fullerton, California, United States, 92835
    Completed
    Retina-Vitreous Associates Medical Group
    Beverly Hills, California, United States, 90211
    Completed
    Retina Centers PC
    Tucson, Arizona, United States, 85704
    Completed
    Retina Northwest PC
    Portland, OREGON, United States, 97221
    Completed
    Florida Eye Clinic
    Altamonte Springs, Florida, United States, 32701
    Completed
    Florida Eye Associates
    Melbourne, Florida, United States, 32901
    Completed
    Colorado Retina Associates
    Golden, Colorado, United States, 80214
    Completed
    Illinois Eye Center
    Peoria, Illinois, United States, 61615
    Completed
    Retina Research Institute of Texas
    Abilene, Texas, United States, 79606
    Completed
    VitreoRetinal Surgery
    Minneapolis, Minnesota, United States, 55435
    Completed
    Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Szemeszeti Klinika
    Szeged, Hungary, 6702
    Completed
    Pauls Stradins Clinical University Hospital, Clinic of Ophthalmology
    Riga, Latvia, LV-1002
    Completed
    Peterfy Sandor utcai Korhaz-Rendelointezet es Baleseti Kozpont
    Budapest, Hungary, 1076
    Completed
    Budapest Retina Associates
    Budapest, Hungary, 1133
    Completed
    Dr. Solomatin's eye rehabilitation and vision correction centre
    Riga, Latvia, LV-1050
    Completed
    Mid Atlantic Retina
    Philadelphia, Pennsylvania, United States, 19107

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?